QRX 0.00% 2.8¢ qrxpharma ltd

update: qrx

  1. 165 Posts.
    lightbulb Created with Sketch. 5
    Similar story

    2 drugs on their way to phase three trials. Simple process, with protection of intellectual capital.

    Will target $11bn p.a. US pain relief market

    Very experienced board (Resmed) and lots of cash following underwritten rights issue.

    Unfairly punished following rights issue at 80cents.

    This one will hopefully allow me to retire.

    HOWEVER - new capital raising, cashed up and ready to bring two new drugs to the market.
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.